More additions to the Samsara Therapeutics team

We’re pleased to report that we’ve further strengthened our team in Oxford. Matthew Williamson is an expert in stem cells and patient-derived assays for Parkinson’s Disease, an important capability for us to generate key data needed to move our lead compounds to the clinic in this disease. Meanwhile James Taylor has extensive experience in screening technologies and will be helping us to identify new autophagy-inducing molecules. Both come direct from Oxford University. At the same time Natalia Pinzon joins us to manage our growing administration needs. Natalia has a business background and previous experience supporting early stage companies.